Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Curcumin, EGCG, barringtozenol, and finasteride are effective VEGFR inhibitors.

Testosterone undecanoate can reduce the negative effects of Finasteride on male reproductive health.

Early diagnosis and quick treatment improve life quality for FFA patients.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

The combination of encorafenib and binimetinib caused few skin issues.

Tofacitinib effectively promotes hair regrowth in children with alopecia areata, but more research on long-term safety is needed.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Selective androgen receptor modulators (SARMs) are a promising type of drug for various health conditions due to their targeted actions.

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

INTASYL is a promising, adaptable RNAi technology for treating skin cancers.

Nanostructured lipid carriers can improve finasteride delivery for better hair loss treatment.

Early diagnosis of frontal fibrosing alopecia is crucial to prevent permanent hair loss.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

Flammulina velutipes polysaccharide helps the immune system fight tumors by activating certain pathways.

A new Wnt surrogate specifically targets the Frizzled7 receptor, promoting organoid formation and hair growth.

Aromatase inhibitors cause male pattern hair loss in women.

5-Fluorouracil causes hair loss by blocking signals needed for hair growth.